Global Myopia and Presbyopia Treatment Market Size (2024 - 2029)

The market size for myopia and presbyopia treatment is experiencing significant growth, driven by the increasing prevalence of vision impairment and a rapidly aging population globally. The rise in screen time during the COVID-19 pandemic has exacerbated eyesight issues, contributing to this expansion. Governments are responding by enhancing patient access and increasing the number of eye clinics, which is further boosting the market. The demand for various treatment options, including lenses and surgical procedures, is rising as the incidence of conditions associated with high myopia, such as retinal damage and cataracts, continues to grow.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Ophthalmic Drugs Research Myopia and Presbyopia Treatment Market Market Size

Market Size of Global Myopia and Presbyopia Treatment Industry

Myopia and Presbyopia Treatment Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 26.13 Billion
Market Size (2029) USD 33.53 Billion
CAGR (2024 - 2029) 5.11 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Myopia and Presbyopia Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Myopia and Presbyopia Treatment Market Analysis

The Global Myopia and Presbyopia Treatment Market size is estimated at USD 26.13 billion in 2024, and is expected to reach USD 33.53 billion by 2029, growing at a CAGR of 5.11% during the forecast period (2024-2029).

The market for myopia and presbyopia is currently growing at a healthy rate, which is majorly associated with the rising number of people with vision impairment and the rapid growth in the geriatric population worldwide.

The COVID-19 pandemic is an unprecedented health concern adversely affecting communities, industries, businesses, and lives worldwide. Great damage has been observed in people's eyesight due to increased screen time. For instance, according to a survey report published in July 2021 by the UK-based Feel Good Contacts, in 2020, due to the lockdown, Indians suffered maximum damage to eyesight due to increased screen time. About 27.5 crore Indians, about 23% of the population, reported their eyesight weakening because of excessive screen time. Moreover, the study Progression of Myopia in School-Aged Children After COVID-19 Home Confinement noted a substantial myopic shift (0.3 diopters) after home confinement amongst children aged 6-8 years.

The prevalence of myopia increased from 1.4 to 3 in 2020 compared to the previous five years globally. The prevalence of vision impairment issues such as myopia is increasing globally at an alarming rate, with significant increases in vision impairment risks from pathologic conditions associated with high myopia, including retinal damage, cataract, and glaucoma. These diseases are causing an elevation in the incidence of visual impairment. The demand for treatment options, like contact, concave, or prescription lenses, has increased tremendously worldwide.

Various countries' governments are focusing on improving patient flow, for which they are also considering increasing the number of eye clinics. The increasing number of eye clinics is augmenting the rise in the procedural volume of eye surgeries, favoring the market studied.

Myopia and Presbyopia Treatment Industry Segmentation

As per the scope of the report, myopia is the condition in which incoming light does not directly focus on the retina but in front of it. Presbyopia becomes more frequent. Presbyopia is the condition in which incoming light focuses behind the retina, leading to difficulty focusing on close-up objects. The Myopia and Presbyopia Treatment Market is Segmented by Disease Type (Myopia and Presbyopia), Treatment Type (Prescription Lenses, Contact Lenses, Surgery, and Medication), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Disease Type
Myopia
Presbyopia
By Treatment Type
Prescription Lenses
Contact Lenses
Surgery
Medication
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Myopia and Presbyopia Treatment Market Size Summary

The global myopia and presbyopia treatment market is experiencing robust growth, driven by the increasing prevalence of vision impairment and a rapidly aging population worldwide. The market is expanding due to the rising number of individuals affected by myopia and presbyopia, conditions exacerbated by factors such as increased screen time during the COVID-19 pandemic and reduced outdoor activities. This surge in vision impairment has led to a heightened demand for various treatment options, including corrective lenses and refractive surgeries. Governments are responding by enhancing patient flow and expanding the number of eye clinics, which in turn is boosting the volume of eye surgeries and supporting market expansion. The economic impact of uncorrected myopia, with significant productivity losses, further underscores the importance of effective treatment solutions.

Regionally, North America holds the largest market share, benefiting from advanced healthcare infrastructure and a wide range of treatment options. Meanwhile, the Asia-Pacific region is witnessing the fastest growth, fueled by increasing awareness and adoption of treatment options. The competitive landscape is marked by the presence of major players such as ALCON Inc., Bausch Health Companies Inc., and Johnson & Johnson Vision, who are actively launching new products and initiatives to raise awareness. Recent approvals, such as Allergan's Vuity for presbyopia and Johnson & Johnson's ACUVUE Abiliti lenses for myopia progression, highlight the ongoing innovation and strategic efforts within the market. These developments are expected to drive continued growth and address the rising global demand for effective myopia and presbyopia treatments.

Explore More

Global Myopia and Presbyopia Treatment Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Cases of Vision Impairment

      2. 1.2.2 Rising Geriatric Population

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Early Diagnosis

      2. 1.3.2 High Cost of Treatment

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Disease Type

      1. 2.1.1 Myopia

      2. 2.1.2 Presbyopia

    2. 2.2 By Treatment Type

      1. 2.2.1 Prescription Lenses

      2. 2.2.2 Contact Lenses

      3. 2.2.3 Surgery

      4. 2.2.4 Medication

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Myopia and Presbyopia Treatment Market Size FAQs

The Global Myopia and Presbyopia Treatment Market size is expected to reach USD 26.13 billion in 2024 and grow at a CAGR of 5.11% to reach USD 33.53 billion by 2029.

In 2024, the Global Myopia and Presbyopia Treatment Market size is expected to reach USD 26.13 billion.

Myopia and Presbyopia Treatment Market Report Snapshots

Myopia and Presbyopia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)